Facet helps to develop products in every therapeutic area and has specialty expertise in ophthalmology, oncology, diagnostic/therapeutic radiopharmaceuticals, and controlled substances
Facet’s scientific experts can author any document in a regulatory submission for FDA. We write submissions documents with the FDA reviewer in mind.
Facet is a leading regulatory affairs and development partner in advancing products for rare and ultra rare disease indications
Facet submits 12-15 INDs a year and 3-5 NDA/BLAs a year
Facet team members attend FDA public meetings, FDA-Industry workshops, professional conferences, and working groups monthly to stay on the cutting edge of science, regulatory affairs, and product development